Page last updated: 2024-12-07

2'-o-methyluridine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

2'-O-methyluridine (2'-OMeU) is a modified nucleoside found in RNA. It is formed by methylation of the 2'-hydroxyl group of uridine. 2'-OMeU is a common modification in various RNA species, including messenger RNA (mRNA), ribosomal RNA (rRNA), and transfer RNA (tRNA). 2'-OMeU has been shown to play a role in RNA stability, translation efficiency, and RNA structure. Its presence can influence the interactions of RNA with proteins and other molecules. 2'-OMeU is often studied in the context of RNA structure and function, and its role in various biological processes. It is also of interest in the development of novel therapeutic agents, as it can be incorporated into synthetic RNA molecules to modulate their properties.'

Cross-References

ID SourceID
PubMed CID102212
CHEBI ID19227
SCHEMBL ID25866
MeSH IDM0148258

Synonyms (28)

Synonym
1-((2r,3r,4r,5r)-4-hydroxy-5-(hydroxymethyl)-3-methoxytetrahydrofuran-2-yl)pyrimidine-2,4(1h,3h)-dione
uridine, 2'-o-methyl-
2140-76-3
2'-o-methyluridine ,
1-[(2r,3r,4r,5r)-4-hydroxy-5-(hydroxymethyl)-3-methoxyoxolan-2-yl]pyrimidine-2,4-dione
o(2')-methyluridine
399vzb6tmb ,
unii-399vzb6tmb
AKOS015919383
CHEBI:19227
o2'-methyluridine
2 inverted exclamation marka-o-methyluridine
AKOS015850961
SCHEMBL25866
J-700070
mfcd00056054
2'-o-methyl-uridine
2'-o-methyluridine, aldrichcpr
CS-W012540
DTXSID10943959
4-hydroxy-1-(2-o-methylpentofuranosyl)pyrimidin-2(1h)-one
AS-12177
Q15632791
HY-W011824
EN300-19734319
1-[(2r,3r,4r,5r)-4-hydroxy-5-(hydroxymethyl)-3-methoxyoxolan-2-yl]-1,2,3,4-tetrahydropyrimidine-2,4-dione
BP-58662
PD158289
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
methyluridineA uridine bearing one or more methyl substituents.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (14)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (7.14)18.7374
1990's5 (35.71)18.2507
2000's1 (7.14)29.6817
2010's7 (50.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 23.51

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index23.51 (24.57)
Research Supply Index2.71 (2.92)
Research Growth Index5.63 (4.65)
Search Engine Demand Index21.17 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (23.51)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other14 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]